ELAN – Elanco Animal Health Incorporated

Elanco Animal Health Incorporat

ELAN

$11.02

Name : Elanco Animal Health Incorporat

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $5,447,770,112.00

EPSttm : 0.41

Elanco Animal Health Incorporat

$11.02

0.99%

$0.11

Float Short %

3.38

Margin Of Safety %

-2

Put/Call OI Ratio

0.97

EPS Next Q Diff

0.17

EPS Last/This Y

EPS This/Next Y

-0.02

Price

11.01

Target Price

17.33

Analyst Recom

1.88

Performance Q

-18.07

Relative Volume

1.61

Beta

1.44

Ticker: ELAN

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-01-23	ELAN	12.05	0.64	0.38	20506
2025-01-24	ELAN	12.07	0.64	8.27	20586
2025-01-27	ELAN	12.07	0.73	1.65	21956
2025-01-28	ELAN	12.15	0.73	0.11	22017
2025-01-29	ELAN	12.28	0.72	0.38	22123
2025-01-30	ELAN	12.47	0.73	0.38	22232
2025-01-31	ELAN	12.02	0.72	0.35	22312
2025-02-03	ELAN	11.72	0.71	1.90	22515
2025-02-04	ELAN	11.5	0.71	0.15	22485
2025-02-05	ELAN	12.05	0.69	0.01	22870
2025-02-06	ELAN	11.97	0.68	0.58	23063
2025-02-07	ELAN	11.51	0.65	0.47	23473
2025-02-10	ELAN	11.49	0.65	0.24	23459
2025-02-11	ELAN	11.42	0.66	0.34	23444
2025-02-12	ELAN	11.38	0.65	0.43	23576
2025-02-13	ELAN	11.65	0.65	0.70	24497
2025-02-14	ELAN	11.26	0.68	10.24	26046
2025-02-18	ELAN	11.34	0.96	2.94	31260
2025-02-19	ELAN	11.23	0.97	34.87	31342
2025-02-20	ELAN	11.13	1.08	0.50	33160
2025-02-21	ELAN	11.01	0.97	0.89	31696
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-01-23	ELAN	12.06	86.6	-175.9	0.92
2025-01-24	ELAN	12.07	86.6	-174.6	0.92
2025-01-27	ELAN	12.06	86.6	-175.4	0.92
2025-01-28	ELAN	12.15	86.6	-173.0	0.92
2025-01-29	ELAN	12.28	87.1	-172.1	0.92
2025-01-30	ELAN	12.47	87.1	-170.5	0.92
2025-01-31	ELAN	12.03	87.1	-185.6	0.92
2025-02-03	ELAN	11.72	87.1	-182.6	0.92
2025-02-04	ELAN	11.50	87.1	-180.5	0.92
2025-02-05	ELAN	12.02	87.1	-161.8	0.92
2025-02-06	ELAN	11.96	87.1	-176.6	0.92
2025-02-07	ELAN	11.52	87.1	-186.1	0.92
2025-02-10	ELAN	11.48	87.1	-176.0	0.92
2025-02-11	ELAN	11.42	87.1	-176.4	0.92
2025-02-12	ELAN	11.37	87.1	-179.7	0.92
2025-02-13	ELAN	11.66	87.1	-171.5	0.92
2025-02-14	ELAN	11.25	87.1	-188.9	0.92
2025-02-18	ELAN	11.33	87.1	-176.6	0.92
2025-02-19	ELAN	11.24	87.1	-180.7	0.92
2025-02-20	ELAN	11.14	87.1	-181.2	0.92
2025-02-21	ELAN	11.01	85.7	-181.7	0.92
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-01-23	ELAN	1.43	-0.81	3.12
2025-01-24	ELAN	1.43	-0.81	3.12
2025-01-27	ELAN	1.43	-0.78	3.12
2025-01-28	ELAN	1.43	-0.78	3.42
2025-01-29	ELAN	1.43	-0.78	3.42
2025-01-30	ELAN	1.43	-0.78	3.42
2025-01-31	ELAN	1.43	-0.78	3.42
2025-02-03	ELAN	1.43	-0.83	3.42
2025-02-04	ELAN	1.43	-0.83	3.42
2025-02-05	ELAN	1.43	-0.83	3.42
2025-02-06	ELAN	1.43	-0.83	3.42
2025-02-07	ELAN	1.43	-0.83	3.42
2025-02-10	ELAN	1.43	-0.87	3.42
2025-02-11	ELAN	1.28	-0.87	3.42
2025-02-12	ELAN	1.28	-0.87	3.41
2025-02-13	ELAN	1.28	-0.87	3.41
2025-02-14	ELAN	0.04	-0.87	3.41
2025-02-18	ELAN	0.05	-0.79	3.41
2025-02-19	ELAN	0.09	-0.79	3.38
2025-02-20	ELAN	0.09	-0.79	3.38
2025-02-21	ELAN	0.09	-0.79	3.38
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.13

Avg. EPS Est. Current Quarter

0.15

Avg. EPS Est. Next Quarter

0.3

Insider Transactions

0.09

Institutional Transactions

-0.79

Beta

1.44

Average Sales Estimate Current Quarter

1012

Average Sales Estimate Next Quarter

1209

Fair Value

10.84

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

70.6

Max Drawdown 5-Year %

-78

Target Price

17.33

P/E

26.97

Forward P/E

12.34

PEG

5.18

P/S

1.22

P/B

0.84

P/Free Cash Flow

14.34

EPS

0.41

Average EPS Est. Cur. Y

0.92

EPS Next Y. (Est.)

0.9

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.6

Relative Volume

1.61

Return on Equity vs Sector %

-16.1

Return on Equity vs Industry %

-4.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-181.7

Elanco Animal Health Incorporat

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 9300

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

stock quote shares ELAN – Elanco Animal Health Incorporated Stock Price stock today

news today ELAN – Elanco Animal Health Incorporated stock forecast ,stock prediction 2023 2024 2025

marketwatch ELAN – Elanco Animal Health Incorporated yahoo finance google finance

stock history ELAN – Elanco Animal Health Incorporated invest stock market

stock prices ELAN premarket after hours

ticker ELAN fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

ELAN – Elanco Animal Health Incorporated

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ELAN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y